Home Your basket
• Laryngeal tuberculosis: a...
   Price 8.50 €
• Follow up of tracheostoma...
   Price 12.00 €
• Laryngeal tuberculosis: A...
   Price 5.50 €
• Management of peritonsill...
   Price 5.50 €
• Importance of a molding n...
   Price 10.50 €
• Otogenic pneumocephalus: ...
   Price 5.50 €
• Diagnostic value of vibra...
   Price 8.50 €
• Free novascularized bone ...
   Price 15.00 €
• The place of speech thera...
   Price 8.50 €
• Parapharyngeal tumours: M...
   Price 10.50 €
• Thyroid surgery (356 case...
   Price 10.50 €
• Distortion product otoaco...
   Price 10.50 €
• Anatomic evaluation of th...
   Price 10.50 €
• Teeth and sinuses...
   Price 8.50 €
• Aspects of voice quality ...
   Price 5.50 €
• From intelligibility to c...
   Price 10.50 €
• New potentialities of the...
   Price 12.50 €
• Velo-pharyngeal incompete...
   Price 14.00 €
• Karapandzic flap for reco...
   Price 10.50 €
• Adaptation and validation...
   Price 10.50 €
• How I do it: Salivary duc...
   Price 8.50 €
• Positioning in the oropha...
   Price 8.50 €
• Salvage composite resecti...
   Price 10.50 €
• Management of a huge amel...
   Price 5.50 €
• Free sorting task of spee...
   Price 10.50 €
• Perilymphatic Gusher as a...
   Price 10.50 €
• New indications for heari...
   Price 8.50 €
• Implication of mitochondr...
   Price 10.50 €
• Sentinel lymph node biops...
   Price 10.50 €
• The European Evaluation o...
   Price 8.50 €
• Peritonsillar abscess: Is...
   Price 10.50 €
• Electrorhinomanometric ev...
   Price 10.50 €
• Objective tinnitus and es...
   Price 5.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Postural control accordin...
   Price 10.50 €
• Principes underlying the ...
   Price 10.50 €
• Parathyroïd adenoma induc...
   Price 8.50 €
• Comparison of radical (na...
   Price 10.50 €
• Prognostic value of senti...
   Price 10.50 €
• Hearing preservation in p...
   Price 10.50 €
• Management of cerebellopo...
   Price 10.50 €
• Side effects and patients...
   Price 10.50 €

Total Order 404.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

RHINOLOGY

Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).


Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.

Article published in french
Downloadable PDF document french



Summary : The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE